Comprehensive Quality Control And Traceability System

The quality control of Chiba needles runs through the entire manufacturing process, and there are strict standards and testing methods at every stage.
The size inspection adopts a multi-technology integration approach. The outer diameter and wall thickness are measured using a laser diameter gauge with an accuracy of ±0.001mm, and 100% full inspection is conducted. The inner diameter is measured using an air piston gauge with an accuracy of ±0.002mm. The length is measured using an optical projector with an accuracy of ±0.01mm. The tip geometry is measured using a three-dimensional profilometer with a resolution of 0.1μm.
Mechanical performance tests simulate actual usage. The puncture force test uses a standard gelatin model (concentration 10%, temperature 37℃), with a puncture speed of 10mm/s, to measure the maximum and average puncture forces. The bending stiffness test employs the three-point bending method, with a span of 20mm and a loading speed of 1mm/min, to measure the elastic modulus. The torsional strength test applies torque until failure, with a 22G needle having a minimum torque of 0.05N·m.
Functional performance verification ensures clinical efficacy. Flow tests measure the suction and injection capabilities: at a negative pressure of 0.1 MPa, it takes no more than 3 seconds to suction 5 mL of water; at a positive pressure of 0.1 MPa, it takes no more than 2 seconds to inject 5 mL of water. Sealing tests maintain pressure for 30 seconds at 0.3 MPa without leakage. Lug joint tests follow the ISO 80369 standard; the connection force is 5-15 N, and the rotation torque is 0.1-0.3 N·m.
The biocompatibility test follows ISO 10993. The cytotoxicity test uses the MTT method. The extract solution is prepared at a concentration of 3 cm²/mL, and is left to soak at 37°C for 72 hours. The cell survival rate is ≥ 80%. The sensitization test adopts the maximum method, and the reaction of guinea pig skin is ≤ mild erythema. The genotoxicity test is conducted through the Ames test and chromosome aberration test.
The traceability system ensures full-process monitoring. Each needle has a unique identification code, which records the batch of raw materials, processing parameters, test data, and operators. Through the MES system, any quality issues can be traced back to the specific process and the responsible person. The data retention period is at least 10 years, meeting the requirements of FDA 21 CFR Part 820.
Intelligent Manufacturing and Future Trends
The manufacturing of Chiba needles is moving towards an intelligent and digital direction. The digital twin technology creates virtual manufacturing models, simulates the processing process, optimizes process parameters, and shortens the trial production cycle from 2 weeks to 2 days. Artificial intelligence analyzes production data, predicts quality trends, and adjusts parameters in advance, reducing the defect rate from 500 ppm to 50 ppm.
The automated production line enhances consistency. Robots handle loading and unloading, inspection, and packaging, reducing human intervention by 80%. The visual system automatically identifies defects with an accuracy rate of 99.9%. The adaptive control system adjusts processing parameters in real time to compensate for tool wear and temperature changes.
Personalized customization meets special needs. Based on the patient's CT data, 3D printing is used to manufacture personalized needles, optimizing the needle tip angle and curvature for specific anatomical structures. Small-batch flexible production is adopted, with the minimum order quantity reduced from 1,000 to 100, and the delivery time shortened from 4 weeks to 1 week.
Green manufacturing reduces environmental impact. Water-based cleaning agents replace organic solvents, with wastewater reuse rate exceeding 90%. Dry cutting reduces the use of coolant. Material utilization rate has increased from 60% to 85%. Packaging uses degradable materials, with carbon footprint reduced by 40%.
The manufacturing of Chiba needles is an art of precision engineering, and it is also a respect for life. From raw materials to finished products, every step involves the craftsmanship and responsibility of the manufacturers. In this world with a diameter of less than 1 millimeter, precision determines the effect, and quality concerns life. Only those manufacturers who master the core techniques, adhere to the highest standards, and continuously innovate and iterate can provide reliable tools for precision medicine, helping doctors create miracles of life in the microscopic world.
Clinical Application Progress and Technological Innovation of Chiba Needle
Since its development by the Department of Medicine of Chiba University in Japan in 1970, the Chiba Needle has evolved from a simple biliary puncture tool to an indispensable multi-functional instrument in the field of interventional radiology. In today's era of rapid development in imaging guidance technology, the application scope of the Chiba Needle is constantly expanding, and technological innovations are constantly emerging, which is redefining the boundaries of minimally invasive diagnosis and treatment.
Percutaneous biopsy: From tissue sampling to molecular diagnosis
Percutaneous biopsy is the most classic application of the Chiba needle. However, modern biopsy is far more than just obtaining tissue specimens. In CT-guided lung nodule biopsy, the diagnostic accuracy of the 22G Chiba needle (outer diameter 0.7mm) is 92-95%, the incidence of pneumothorax is 12-15%, and the incidence of bleeding is 5-8%. But simple histological diagnosis alone cannot meet the needs of precision medicine.
The coaxial technique has elevated biopsy to a new level. A 19G guiding needle (outer diameter 1.0mm) creates a channel, and a 22G biopsy needle takes multiple samples through the coaxial sheath, obtaining 3-5 tissue strips, each 1.5-2.0cm in length. This technique increases the diagnostic rate to 97%, while reducing the number of pleural punctures and lowering the pneumothorax rate to 8%. What's more advanced is the tandem technique, where two needles are punctured simultaneously, with one needle used for biopsy and the other for marking, providing precise positioning for subsequent surgeries or ablations.
Molecular biopsy opens up new horizons. The tissues obtained through the Kashima needle are not only used for pathological diagnosis but also for genetic testing. In lung cancer biopsy, the obtained tissues must meet the requirements of next-generation sequencing (NGS): the content of tumor cells should be >20%, the total amount of DNA should be >50ng, and the fragment length should be >200bp. The average weight of the tissues obtained by the 22G needle is 15mg, and the DNA yield is 30-50ng/mg, which is sufficient for panel testing of 50-100 genes. This makes individualized targeted therapy possible. The accuracy rate of EGFR mutation detection is 95%, guiding the use of targeted drugs such as gefitinib.
Liquid biopsy is combined with tissue biopsy. During the puncture, 3-5 mL of normal saline is injected through the Kashima needle, and the "puncture fluid" is retrieved by aspiration to detect circulating tumor DNA (ctDNA). The study shows that the concentration of ctDNA in the puncture fluid is 100-1000 times that of peripheral blood, and the detection rate of EGFR mutations increases from 70% in plasma to 95%. This "one-needle dual-test" mode maximizes diagnostic information and is particularly suitable for cases with limited tissue samples.
Percutaneous puncture drainage: From simple drainage to complex management
The application of the Chiba needle in the field of drainage has evolved from simple cyst aspiration to complex drainage of abscesses, hematomas, and bile. Under ultrasound guidance, liver cyst puncture is performed using a 18G Chiba needle (outer diameter 1.2mm) to aspirate the cyst fluid, and sclerosing agents (such as anhydrous ethanol) are injected for treatment. The cure rate is 85-90%, and the recurrence rate is 10-15%. However, modern drainage places greater emphasis on the entire management process.
The technique of pancreatic pseudocyst drainage has witnessed significant progress. Using a 19G Chiba needle under CT guidance to puncture the cyst, and then inserting an 8-10F drainage tube through Seldinger technique. However, the recurrence rate of simple drainage is 20-30%. Now, combined with endoscopic placement of a stent through the stomach or duodenum, establishing a cyst-gastrointestinal internal drainage system, the long-term cure rate has increased to 90%. What's even more innovative is ultrasound endoscopy-guided puncture, directly entering the cyst through the stomach wall, with less trauma and lower infection risk.
Technological innovations in liver abscess drainage. Previously, a 12-14F thick tube was used for drainage, but it caused strong discomfort to the patients. Now, an 8.5F Kashima needle is used for puncture, and an 8F multi-hole drainage tube is inserted. Combined with pulse irrigation (using 20mL of normal saline for rapid injection and flushing every 4 hours), the drainage efficiency has increased by 30%. For multiple-faceted abscesses, a turnable Kashima needle (with a 30° bendable tip) is used to puncture each compartment one by one, increasing the success rate from 60% to 85%.
The evolution of biliary drainage techniques. Percutaneous transhepatic cholangial drainage (PTCD) is the classic application of the Chiba needle, but the traditional method requires multiple punctures and has a high complication rate. Now, with the use of ultrasound and fluoroscopy for dual guidance, 21G Chiba needles are used for puncture. Once bile flows out, contrast agent is injected to clearly identify the biliary anatomy, and then a drainage tube is inserted. This improved technique has increased the success rate of a single puncture from 70% to 90%, and the bleeding complication rate has decreased from 8% to 3%. For biliary obstruction at the hepatic hilum, the coaxial technique is used to insert multiple drainage tubes to drain the left and right hepatic ducts separately. The jaundice regression rate has increased from 65% to 85%.
Vascular Intervention: From Pathway Establishment to Complex Operations
The Kailian needle plays the role of "gate opener" in vascular intervention, but its modern applications go far beyond simple puncture. In transjugular intrahepatic portosystemic shunt (TIPS) procedures, the Kailian needle is used to puncture the hepatic veins to the portal vein to establish a shunt channel. Using a 16G Kailian needle (outer diameter 1.6mm) under ultrasound guidance for puncture, combined with portal vein angiography, the success rate is 95-98%. However, the traditional method had a liver artery injury rate of 3-5%, while now with real-time ultrasound guidance and avoiding the branches of the hepatic artery, the injury rate has dropped to below 1%.
Technological advancements in establishing dialysis access. For patients with poor vascular conditions, the use of a micro-puncture kit is recommended: 21G Chiba needle puncture, 0.018-inch guidewire insertion, and gradual dilation to a 6F sheath. This micro-puncture technique reduces the incidence of hematoma from 15% to 3%, and is particularly suitable for obese patients. What's more advanced is the ultrasound fusion technology, which combines CT vascular imaging with real-time ultrasound to virtually display the vascular path, and the puncture success rate is close to 100%.
Innovative Applications in Tumor Embolization. In transarterial chemoembolization (TACE) for hepatocellular carcinoma, the Kashima needle is used for puncturing the femoral artery, but modern techniques are more refined. A 4F microcatheter is used for super-selective insertion into the tumor-feeding arteries, and drug-loaded microspheres (diameter 100-300 μm) are injected through the Kashima needle, resulting in more thorough embolization with less damage to normal liver tissue. Combined with CT-guided radiofrequency ablation, the 3-year survival rate has increased from 50% to 70%.
Sclerotherapy for varicose veins. Under ultrasound guidance, a Chiba needle is used to puncture the varicose veins and inject foam sclerosing agent (polydocanol mixed with air in a 1:4 ratio). The multi-side needle tip design ensures a more uniform distribution of the sclerosing agent, reducing the recurrence rate from 30% to 15%. For great saphenous varicose veins, a laser fiber is used to enter the vein through the Chiba needle for intracavitary laser closure. The success rate is 98%, and the recovery time is shortened from 2 weeks to 3 days.
Pain treatment: From nerve block to intervertebral disc therapy
The application of Kailian needles in pain treatment is becoming increasingly widespread, with extremely high precision requirements. For the treatment of post-zoster neuralgia with paravertebral nerve block, a 25G Kailian needle (outer diameter 0.5mm) is inserted into the paravertebral space under CT guidance and local anesthetic and hormones are injected. The traditional method relies on bony landmarks, with a success rate of 80%, while the current method uses three-dimensional CT reconstruction to display the needle tip position in real time, increasing the success rate to 95%.
Intervertebral disc imaging and treatment. Using a 22G Chiba needle to puncture the intervertebral disc and inject contrast agent to assess the integrity of the annulus fibrosus, diagnosing discogenic pain. What's more innovative is the intradiscal electrothermal therapy (IDET), where a heat-cooling catheter is inserted through the Chiba needle, heated to 90°C for 5 minutes, causing the contraction of collagen fibers and sealing the tear site. The pain relief rate is 70-80%.
Radiofrequency ablation of the trigeminal ganglion. Using a 22G Chiba needle to puncture through the foramen ovale to the trigeminal ganglion, with the needle tip exposed for 5mm. The radiofrequency is applied to heat it to 70°C for 90 seconds to treat trigeminal neuralgia. The traditional method relied on X-ray fluoroscopy, while now it is guided by CT, which can clearly show the relationship between the needle tip and the skull base, avoiding puncture of the cavernous sinus. The incidence of serious complications has decreased from 2% to 0.5%.
Joint intervention therapy. For shoulder joint imaging, a 22G Chiba needle is used to puncture the joint cavity and inject contrast agent to assess rotator cuff injuries. More therapeutic is the puncture and irrigation of calcific tendinitis, where a 18G needle is used to puncture the calcified lesion, inject normal saline for irrigation, and remove the calcified substances. The pain relief rate is 85%. Ultrasound guidance makes the puncture more precise, increasing the success rate from 75% to 95%.
Tumor ablation: From thermal ablation to irreversible electroporation
The Chiba needle not only serves as a puncturing tool but also acts as an energy transmission channel in tumor ablation. For the treatment of small liver cancer using radiofrequency ablation, a 17G Chiba needle (with an outer diameter of 1.4mm) equipped with internal electrodes is used. The needle tip is expanded into multiple sub-needles, creating an ablation zone with a diameter of 3-5cm. However, traditional radiofrequency ablation is affected by blood flow heat dissipation. Now, bipolar radiofrequency is adopted, with two Chiba needles simultaneously puncturing the two ends of the tumor, resulting in more uniform ablation and a local recurrence rate reduced from 15% to 8%.
Advances in microwave ablation technology. Utilizing 14G Kashima needles with built-in microwave antennas, at a frequency of 2450 MHz, with a power of 60-100W, and a duration of 5-10 minutes, the ablation zone reaches a temperature of 60-100℃. Microwave ablation is not affected by tissue carbonization, and the ablation area is larger and more regular. For large liver cancers (＞5cm), multi-needle synchronous ablation is adopted, with 3-5 Kashima needles working simultaneously, increasing the complete ablation rate from 60% to 85%.
Innovative application of irreversible electroporation (nanoknife). Using a 19G Chiba needle electrode, puncture the tumor under ultrasound or CT guidance, with a needle spacing of 1.5-2.0 cm, applying high-voltage electrical pulses (1500V/cm, 70-90 pulses) to cause nanoscale perforations in the cell membrane and induce cell apoptosis. This non-thermal ablation retains vascular and biliary structures, suitable for tumors at the hepatic hilum and reducing the biliary stenosis rate from 30% to 5%.
Precise control of cryoablation. Utilizing a 17G Chiba needle with an internal liquid nitrogen circulation channel, the tip temperature is reduced to -160℃, creating an ice ball to ablate the tumor. Real-time ultrasound monitoring of the ice ball formation is employed to avoid damage to surrounding tissues. For renal tumors, the renal function protection provided by cryoablation is superior to surgical resection, with a decrease in glomerular filtration rate of only 10% (compared to 30% for surgical resection).
Future Outlook: Intelligent Needles and Precise Navigation
The future of Chiba needles lies in intelligence and precision. The optical fiber sensing needles integrate optical fiber Bragg gratings, which can measure the hardness, temperature and pressure of tissues in real time, distinguish between tumors and normal tissues, with an accuracy rate of 95%. The impedance sensing needles measure the electrical resistance of tissues, identify tissue types, and distinguish between solid nodules and atelectasis in lung biopsies, with an accuracy rate of 90%.
Magnetic resonance compatible needles open up new horizons. Made of nickel-titanium alloy or carbon fiber, they produce minimal artifacts under 3T MRI and allow real-time monitoring of the ablation process. Laser-induced thermotherapy (LITT) uses a laser fiber introduced through a needle. Real-time temperature measurement by MRI precisely controls the ablation area, with an edge error of less than 2mm.
Robot-assisted puncture improves accuracy. The robotic arm holds the lancet needle and is guided by CT or MRI, achieving an accuracy of 0.5mm. It is particularly suitable for deep small lesions (less than 1cm). Artificial intelligence plans the puncture path, avoiding blood vessels and important structures, and reducing complications by 50%.
The rotatable needle tip enhances flexibility. The needle tip can be mechanically or thermally activated to bend, with a maximum angle of 30°, enabling curved puncture and circumventing obstacles. It is used for prostate biopsy, covering areas that traditional straight puncture cannot reach, and the cancer detection rate increases by 20%.
The drug delivery needle implements local treatment. The multi-hole design at the needle tip ensures a more uniform distribution of the drug. The sustained-release coating retains chemotherapy drugs in the needle channel and releases them continuously for 7-14 days. The local drug concentration is 100 times that of intravenous administration, and the systemic toxicity is reduced by 80%.
The development history of the Chiba needle is a microcosm of interventional radiology: from simplicity to complexity, from diagnosis to treatment, from ignorance to precision. Each technological innovation has expanded the application scope, and each process improvement has enhanced safety. In the future, with the integration of materials science, imaging technology, and artificial intelligence, the Chiba needle will continue to evolve, taking on a more intelligent, more precise, and more secure form, and writing a new chapter in the vast world of minimally invasive medicine.